News
News Center
2019-08-26
Stroke Forum: Who Will Achieve the First Breakthrough in Stem Cell Therapy for Stroke?
For 20 consecutive years, stroke has been the leading cause of death and disability among Chinese residents. Today, the incidence of stroke continues to rise, with an alarming trend toward younger ages at onset. May the light of regenerative medicine shine brightly on the lives of China's 12.42 million stroke survivors living with long-term disabilities—we’re committed to making this vision a reality!
+
2019-08-21
What precautions should be taken when undergoing stem cell therapy? After undergoing hematopoietic stem cell bone marrow transplantation, will the DNA of the transplanted individual’s blood match that of the recipient? Can mesenchymal stem cells be produced in bulk?
+
2019-08-20
In 2018, Jiuzhitang turned its focus toward the cutting-edge international field of bio-cellular technology by establishing Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. As the sole Chinese partner for stem cell technologies developed by the U.S.-based company Stemedica, the company began pursuing business opportunities related to stem cell research. Meanwhile, Jiuzhitang signed a "Joint Construction Agreement for a Stem Cell Clinical Research Base" with Beijing Tiantan Hospital, Affiliated to Capital Medical University, jointly establishing the "Jiuzhitang Maker Stem Cell Clinical Research Base at Beijing Tiantan Hospital," which has now been completed.
+
2019-07-30
Jiuzhitang is making strides in the stem-cell field, with promising prospects for future growth.
As a national key Chinese medicine enterprise, a national key high-tech enterprise, a national pilot innovative company, and the leading enterprise in Hunan Province’s pharmaceutical industry, Jiuzhitang boasts a rich historical legacy, a strong brand image, and significant industry influence. Now, with its strategic expansion into the stem-cell field, we believe that Jiuzhitang’s future growth prospects are indeed promising.
+
2019-07-05
Biopharmaceuticals are a hot area in 21st-century pharmaceutical research, and stem cells, in particular, are at the cutting edge of this exciting field with incredibly promising prospects.
+
2019-05-30
Great news! Jiuzhitang Maker joins the Chinese Society for Cell Biology.
In May 2019, Jiuzhitang Maker (Beijing) Cell Technology Co. officially joined the Chinese Society for Cell Biology as a corporate member. This move will provide Meike with an even stronger platform for academic exchange and collaboration in stem cell research, opening up more opportunities in the process.
+
2019-02-25
Jiuzhitang Maker Receives the "Zhongguancun High-Tech Enterprise" Certificate
Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. has officially been awarded the "Zhongguancun High-Tech Enterprise" certificate after successfully passing the review by the Zhongguancun Science Park Administrative Committee.
+
2018-11-05
On November 5, 2018, the Daxing District Development and Reform Commission and the Biomedical Base Committee delivered "Comprehensive Service Packages" to ten key high-tech enterprises in the park, offering them concierge-style support. Among these companies was Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
+
2018-10-12
Source: Economic Information Daily Jiuzhitang, a traditional Chinese medicine pharmaceutical company, has recently signed an investment agreement with U.S.-based Stemedica Cell Technologies Inc., a company based in San Diego’s Biotech Valley and boasting over a decade of experience in stem cell research, manufacturing, and marketing. Under the terms of the agreement, Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. will introduce cutting-edge stem cell production technologies and a state-of-the-art preparation platform from one of the world’s leading stem cell firms. Over the next three to five years, Jiuzhitang Maker plans to establish a facility at the Beijing Daxing Biomedical Industry Base that meets both U.S. and EU cGMP standards.
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy